Skip to Main Content

The New Law on Medicines and Its Implementation: El Salvador Case Study

2015

This case study describes El Salvador’s medicine law, introduced in 2012, which created an independent national regulatory agency to modernize and improve inefficient practices in the country’s drug and medical product market. The implementation of this law, which served to regulate prices, access, quality, procurement, prescription, and use of essential medicines, resulted in substantial price reductions and cost savings.

This case is part of the World Health Organization’s collection of health financing policy resources, which includes case studies, reports, policy briefs, and other resources organized by topic. The resource portal also includes information on the WHO’s policy framework for health financing along with relevant World Health Assembly and regional resolutions and strategies, courses and trainings, diagnostics and guidance, and rich data resources including databases and country profiles.

Source:

Yamagiwa TJ. Improving Health System Efficiency: El Salvador: The New Law on Medicines and its Implementation. World Health Organization 2015. https://apps.who.int/iris/handle/10665/186475.